Solesence, Inc. Files 8-K with Financial Updates

Ticker: SLSN · Form: 8-K · Filed: May 7, 2025 · CIK: 883107

Sentiment: neutral

Topics: financial-results, 8-k, company-update

TL;DR

Solesence, Inc. (formerly Nanophase) dropped its 8-K on May 5th with financial results.

AI Summary

On May 5, 2025, Solesence, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits related to the company's performance. Solesence, Inc. was formerly known as Nanophase Technologies Corp.

Why It Matters

This 8-K filing provides crucial updates on Solesence, Inc.'s financial condition and operational results, which are important for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or significant negative events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Solesence, Inc.?

The primary purpose of this 8-K filing is to report on Solesence, Inc.'s results of operations and financial condition, along with providing financial statements and exhibits.

What was Solesence, Inc. previously known as?

Solesence, Inc. was formerly known as Nanophase Technologies Corp and Nanophase Technologies CORPORATION.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on May 5, 2025.

Where are Solesence, Inc.'s principal executive offices located?

Solesence, Inc.'s principal executive offices are located at 1319 Marquette Drive, Romeoville, Illinois 60446.

What is the Standard Industrial Classification code for Solesence, Inc.?

The Standard Industrial Classification code for Solesence, Inc. is 2844, which corresponds to PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding SOLESENCE, INC. (SLSN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing